Cargando…
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis
IMPORTANCE: The chronic receipt of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) has been assumed to exacerbate complications associated with COVID-19 and produce worse clinical outcomes. OBJECTIVE: To conduct an updated and comprehensive systematic review...
Autores principales: | Baral, Ranu, Tsampasian, Vasiliki, Debski, Maciej, Moran, Brendan, Garg, Pankaj, Clark, Allan, Vassiliou, Vassilios S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013817/ https://www.ncbi.nlm.nih.gov/pubmed/33787911 http://dx.doi.org/10.1001/jamanetworkopen.2021.3594 |
Ejemplares similares
-
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
por: Tsampasian, Vasiliki, et al.
Publicado: (2022) -
Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients
por: Baral, Ranu, et al.
Publicado: (2020) -
The Role of SGLT2 Inhibitors in Heart Failure: A Systematic Review and Meta-Analysis
por: Tsampasian, Vasiliki, et al.
Publicado: (2021) -
Biomarkers Associated with Mortality in Aortic Stenosis: A Systematic Review and Meta-Analysis
por: White, Madeline, et al.
Publicado: (2021) -
Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)